Samjo Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,200
Closed -$265K 59
2025
Q4
$265K Sell
5,200
-100
-2% -$5.11K 0.1% 52
2025
Q3
$294K Hold
5,300
0.11% 54
2025
Q2
$366K Hold
5,300
0.15% 51
2025
Q1
$368K Sell
5,300
-100
-2% -$8.26K 0.16% 51
2024
Q4
$465K Hold
5,400
0.18% 46
2024
Q3
$643K Hold
5,400
0.22% 42
2024
Q2
$771K Hold
5,400
0.29% 39
2024
Q1
$693K Sell
5,400
-150
-3% -$17.9K 0.24% 37
2023
Q4
$574K Buy
+5,550
New +$549K 0.2% 35

Other funds holding NVO

Samjo Management's NVO Position: Q1 2026 in Review

Samjo Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,200 shares — an estimated $265K sold.

Samjo Management first reported a position in NVO in Q4 2023 and held it in 9 quarters. The position peaked at $771K in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Samjo Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Samjo Management sold 5,200 Novo Nordisk shares in Q1 2026, an estimated $265K.
  • Samjo Management first reported a position in Novo Nordisk in Q4 2023 and held it in 9 quarters.
  • Samjo Management's Novo Nordisk position peaked at $771K in Q2 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Samjo Management's 13F filing for Q1 2026, filed 15 May 2026.